This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
2024 Circulation Pulmonary 
DAIC
MAY 6, 2024
Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. , Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. , Expanding our intellectual property estate for levosimendan is a strategic priority for Tenax.
Circulation
SEPTEMBER 24, 2024
Circulation, Ahead of Print.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4120743-A4120743, November 12, 2024. However, the most recurrent cardiac complication in RASopathies is pulmonary valve stenosis (PVS). Backgound:The RASopathies are developmental syndromes resulting from variants in the RAS/mitogen-activated protein (MAPK) cascade.
75 
Circulation
JUNE 9, 2024
Circulation, Volume 149, Issue 24 , Page e1412-e1412, June 11, 2024.
45 
Circulation
MAY 27, 2024
Circulation, Volume 149, Issue 22 , Page 1770-1774, May 28, 2024.
45 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4143390-A4143390, November 12, 2024. Introduction:Obesity is rising in prevalence worldwide and co-exists in patients with group 1 pulmonary hypertension (PH). Despite having group 1 PH, pulmonary capillary wedge pressure (PCWP) was higher with obesity (13.8 ± 6.3 vs 9.4 ± 7.7
40 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142839-A4142839, November 12, 2024. Introduction:Inflammation is a key driver in the development of pulmonary arterial hypertension (PAH). The pulmonary vasculature was evaluated histologically. of which are fungi.
40 
Circulation
MAY 12, 2024
Circulation, Volume 149, Issue 20 , Page 1565-1567, May 14, 2024.
45 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4146445-A4146445, November 12, 2024. CD206+Macrophages were accumulated in the pulmonary vessel adventitia of idiopathic PAH (IPAH) patients as well asEgln1Tie2Cremice. RVSP and RV/(LV+S) ratio were measured.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4145487-A4145487, November 12, 2024. reported several cases in which right lower pulmonary vein (RLPV) thrombi extended into the left atrium (LA). Thrombi are difficult to visualize directly and are recognized as lacking in pulmonary vein blood flow.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4122350-A4122350, November 12, 2024. Pulmonary vein thrombi (PVTs) are common and are underestimated. Background:Retrieved thrombus studies have shown that retrieved thrombi have calcifications, indicating that the thrombi are old. In 2022, we reported that 98.6% from 50 y.o.
45 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4141118-A4141118, November 12, 2024. Metabolic abnormalities play a crucial role in the pathophysiological process of pulmonary vascular remodeling. ng/ml; idiopathic pulmonary arterial hypertension group: 5.28 ± 0.77
40 
Circulation
JANUARY 21, 2024
Circulation, Volume 149, Issue 4 , Page 335-338, January 23, 2024.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4144785-A4144785, November 12, 2024. Background:Acquired mitochondrial dysfunction is one of the characteristics of pulmonary arterial hypertension (PAH). Single-cell analysis showed that ARMCX3 was highly expressed in pulmonary vascular smooth muscle cells and endothelial cells.
40 
Circulation
NOVEMBER 24, 2024
Circulation, Volume 150, Issue 22 , Page e467-e467, November 26, 2024.
45 
Circulation: Cardiovascular Imaging
OCTOBER 14, 2024
Circulation: Cardiovascular Imaging, Volume 17, Issue 10 , Page e017514, October 1, 2024.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4136694-A4136694, November 12, 2024. However, retrograde arterial perfusion from the femoral artery can increase left ventricular (LV) afterload, resulting in LV distention which may hamper myocardial recovery and worsen pulmonary congestion. 3.65]; p<0.0001).
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4140065-A4140065, November 12, 2024. Methods:This study was a multicenter retrospective analysis involving consecutive patients who underwent intentional TPVR between May 27, 2014, and September 14, 2023.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4117657-A4117657, November 12, 2024. Background:Primary pulmonary arterial hypertension (PAH) is a disease affecting young subjects. It has very poor prognosis and optimal treatment is not available.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4144822-A4144822, November 12, 2024. Multivariable Cox regression analyses were constructed to assess the relationship between AG and short-term outcomes in sepsis patients complicated by PH.Results:2012 sepsis patients with pulmonary hypertension were included.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4143405-A4143405, November 12, 2024. PH was defined as pulmonary artery (PA) mean pressure >20 mmHg, and PH was classified as isolated precapillary PH and combined pre/postcapillary PH.Results:Of 99 COA patients that underwent RHC, 57 (58%) had PH.
40 
Circulation: Cardiovascular Interventions
JANUARY 20, 2025
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014499, January 1, 2025. BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This
40 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4147910-A4147910, November 12, 2024. Animal studies have shown that mice with TBX1 gene mutations have smaller left pulmonary arteries compared to wild type mice, defined by a reduced left pulmonary artery (LPA) to right pulmonary artery (RPA) ratio.
40 
Dr. Smith's ECG Blog
SEPTEMBER 29, 2024
In other words: 1) infarct of the LAD territory (much of which could be old) and 2) inferior-posterior-lateral infarct. == MY Comment , by K EN G RAUER, MD ( 9/27 /2024 ): == I found today's case insightful for a number of reasons. See Discussion in the June 29, 2024 post of Dr. Smith' ECG Blog ). But because Dr.
110 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4135252-A4135252, November 12, 2024. Background:Pulmonary hypertension (PH) is a major contributor to cardiovascular disease-related morbidity and mortality.
DAIC
DECEMBER 29, 2023
Patients in the study will be randomized to undergo pulmonary vein isolation (PVI) and left atrial posterior wall ablation using the FARAPULSE PFA System, or receive AAD treatment, and followed for three years. Food and Drug Administration approval of the FARAPULSE PFA System in the first quarter of 2024. Circulation.
Circulation: Cardiovascular Interventions
NOVEMBER 5, 2024
Circulation: Cardiovascular Interventions, Volume 17, Issue 12 , Page e013964, December 1, 2024. The strategy for pulmonary vein protection was correctly identified by interventionalist 1 and 2 in 9/12 and 8/12 cases, respectively.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4131838-A4131838, November 12, 2024. CT Abdomen and Pelvis showed an enhancing heterogenous lesion at the left superior renal pole, left adrenal gland lesion, and a pulmonary artery filling defect. Based on this, the highest differential was a clot-in-transit.
40 
Frontiers in Cardiovascular Medicine
JULY 11, 2024
BackgroundThis study aimed to assess the scientific results and activities of premature beats research from a global perspective.MethodsPublications related to premature beats published between 2003 and 2024 were identified and selected from the Web of Science core collection. The most cited references come from the journal named Circulation.
52 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4140664-A4140664, November 12, 2024. A cardiac gated CT detailed the pulmonary vein structure and incidentally revealed bilateral cystic lung changes, leading to a pulmonology referral. These enlargements were new compared with imaging one year prior. He was loaded with amiodarone.
Circulation: Arrhythmia and Electrophysiology
NOVEMBER 29, 2024
Circulation: Arrhythmia and Electrophysiology, Volume 17, Issue 12 , Page e013208, December 1, 2024. BACKGROUND:The pentaspline pulsed field ablation catheter achieves pulmonary vein isolation using 8 stacked, pose-specific applications with rotation. versus 6.12.0 mm;P=0.02).
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142484-A4142484, November 12, 2024. Background:Pulmonary arterial hypertension (PAH) is characterized by an elevation in pulmonary vascular resistance and arterial pressure, culminating in right ventricular failure and mortality.
40 
DAIC
FEBRUARY 2, 2024
milla1cf Fri, 02/02/2024 - 17:02 February 2, 2024 — Biosense Webster, Inc. , The primary endpoint of the analysis was incidence of procedure – or device-related primary adverse events (PAEs) within seven to ninety days of the ablation procedure; the secondary endpoint was the rate of acute pulmonary vein (PV) isolation.1
105 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142231-A4142231, November 12, 2024. Methods:The descriptive, cross-sectional study was conducted in patients with STEMI with a confirmed diagnosis and percutaneous coronary angiography at 108 Military Central Hospital from April 2023 to April 2024. The cut-off point was 14.9
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4123391-A4123391, November 12, 2024. The CardioMEMS PA (pulmonary artery) sensor allows remote pulmonary artery diastolic (PAD) pressure monitoring to adjust diuresis in heart failure with preserved ejection fraction (HFpEF).
Journal of Cardiovascular Pharmacology
SEPTEMBER 5, 2024
Abstract: Extracorporeal membrane oxygenation (ECMO) is a mechanical support treatment modality utilized in patients with refractory cardiac and/or pulmonary failure. Extracorporeal membrane oxygenation (ECMO) is a mechanical support treatment modality utilized in patients with refractory cardiac and/or pulmonary failure.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4135095-A4135095, November 12, 2024. Background:While anticoagulation is crucial for atrial fibrillation (AF) patients to prevent ischemic events, those with thrombocytopenia have a potential increased risk of bleeding. The primary outcome was all-cause inpatient mortality.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4144999-A4144999, November 12, 2024. Current recommendations for pulmonary valve replacement (PVR) in TOF patients use indexed RV endiastolic volume (RVEDVi) to determine timing of PVR. In the presence of obesity, RVEDVi may underestimate the severity of RV volume load.
40 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4145271-A4145271, November 12, 2024. Pulmonary valve involvement is rare in LSE, and development of new disease while on recommended medical therapy represents unusual disease progression. Acute stroke workup was negative, and syncope was attributed to possible brief seizure.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4143092-A4143092, November 12, 2024. LVWS was calculated from pulmonary capillary wedge pressure (PCWP) and LV wall thickness and radius using Law of Laplace and expressed in Pascals (Pa).
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4119267-A4119267, November 12, 2024. Advanced cardiac imaging especially in atypical presentations, can aid in early diagnosis.Case:A 59 year-old man with history of biopsy-proven pulmonary sarcoidosis presented with non exertional chest pain for 2 months.
40 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4143844-A4143844, November 12, 2024.
Ken Grauer, MD
APRIL 13, 2024
That said — most patients eventually do become symptomatic ( Webb and Gatzoulis: Circulation 114: 1645-1653, 2006 ). NOTE: For more on ECG recognition of RVH and/or pulmonary hypertension ( re the qR pattern in lead V1 ) — See ECG Blog #234 and Blog #248. For more on ASD in Adults — Webb and Gatzoulis: Circulation 114: 1645-1653, 2006.
116 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142158-A4142158, November 12, 2024. The RFCs were much more successful at classifying murmurs from the pulmonary and tricuspid valves (AUROC = 0.83 All RFC models were evaluated using the area under their receiver operating characteristic curves (AUROCs). and 0.65, respectively).
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content